Liver Stiffness measurement in the primary care setting detects high rates of advanced fibrosis and predicts liver related events in hepatitis C

Chronic hepatitis C (CHC) is a major public health issue with an estimated global prevalence greater than 71 million cases and over 1.75 million individuals infected annually.[1] Together with chronic hepatitis B (CHB), CHC is accountable for over 1.34 million deaths worldwide annually, being the second highest cause of death from communicable diseases and ranked seventh for all-cause mortality.[2] The rapidly increasing rates of hepatocellular carcinoma (HCC) in the developed world has largely been attributed to increased rates of CHC infection since 1975.

Source: Journal of Hepatology - April 27, 2018 Category: Gastroenterology Authors: Stephen Bloom, William Kemp, Amanda Nicoll, Stuart K. Roberts, Paul Gow, Anouk Dev, Sally Bell, Siddharth Sood, Ian Kronborg, Virginia Knight, Diana Lewis, John Lubel Source Type: research